亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Controlled release tablets of verapamil hydrochloride

        2017-01-19 11:37:48TreephuKimlekTossapornPrasertpornJirametSawantranonChaisanSriwichupongGarnpimolRitthidej

        Treephu Kimlek,Tossaporn Prasertporn,Jiramet Sawantranon, Chaisan Sriwichupong,Garnpimol Ritthidej

        Pharmaceutical Technology Field,Department of Pharmaceutics and Industrial Pharmacy,Faculty of Pharmaceutical Sciences,Chulalongkorn University,Bangkok,Thailand

        Controlled release tablets of verapamil hydrochloride

        Treephu Kimlek*,Tossaporn Prasertporn,Jiramet Sawantranon, Chaisan Sriwichupong,Garnpimol Ritthidej

        Pharmaceutical Technology Field,Department of Pharmaceutics and Industrial Pharmacy,Faculty of Pharmaceutical Sciences,Chulalongkorn University,Bangkok,Thailand

        A R T I C L E I N F O

        Article history:

        Available online 24 November 2015

        Verapamil

        Controlled release

        HPMC

        Sodium alginate

        Verapamil is a calcium channel blocker drug which reduces heart rhythm and blood pressure in high blood pressure patient. The steady state of this drug has to be continually controlled to obtain optimal effcacy.In addition,patient compliance needs to be considered.Therefore,controlled release tablet of verapamil hydrochloride was essentially developed using hydrophilic matrix polymer,namely hydroxypropylmethyl cellulose(HPMC)and sodium alginate,and compared to marketed product[1].HPMC,a pH-independent polymer,hydrates to form a gel layer at the surface of the tablet to sustain the drug release.Sodium alginate,a pH-dependent gelling polymer, converts to insoluble alginic acid after exposure to acidic condition in stomach.The development of verapamil hydrochloride controlled release tablet was to vary the amount of HPMC and sodium alginate.Alteration of the type and quantity of excipients were included.Tablets were prepared by wet granulation method.Physical tests were evaluated on tablet such as appearance,thickness,hardness and weight variation.In dissolution test,USP monograph was followed using USP apparatus II(paddle).UV spectrophotometer was used to measure the amount of drug release[2],and then f1,f2 values were calculated.In assay study,high-pressure liquid chromatography was performed.

        The results showed that all formulations obviously passed the physical tests.The type and amount of polymer signifcantly affected the release of drug.For the effect of the variation in type and amount of rate controlling agents,change in amount of sodium alginate slightly affected the release of the drug while change in amount of HPMC had a great impact because the forming of gel layer at early stage(pH 1.2)created barrier to control the drug release whereas at buffer stage(pH 6.8),sodium alginate swelled and caused a synergistic control release effect (Fig.1a).For other excipients,decrease in the amount of microcrystalline cellulose,used as a disintegrant and magnesium stearate,used as a lubricant could reduce tablet disintegration.Finally,povidone K30 as a binder agent could increase granule compaction but with amount limitation.Formulation with accepted range of drug release in USP monograph was satisfactorily obtained and similar to the marketed product. This formulation contained 2.67%of HPMC and 11.33%of sodium alginate.The f1 and f2 values were 13.30 and 61.49,respectively(Fig.1b).

        Fig.1–Gel layer forming of tablet in acid and buffer condition.(a)Dissolution profle of the selected formulations prepared with small scale and large scale production:HPMC:Sodium alginate=2.67:11.33 compared to marketed product(b).

        Acknowledgement

        The authors acknowledge the fnancial support received from Thailand Center of Excellence for Life Sciences(TCELS).

        R E F E R E N C E S

        [1]Abbott Laboratories.Product Monograph:ISOPTIN?SR [monograph on the Internet],;2011.

        [2]The United States Pharmacopoeial Convention.USP36-NF31, vol.1.2013.p.5556–5563.

        [3]Qiu Y,Zhang G.Development of modifed-release solid oral dosage forms.In:Developing solid oral dosage forms: pharmaceutical theory and practice.2009.p.501–510.

        *E-mail address:tuarus_f@hotmail.com.

        Peer review under responsibility of Shenyang Pharmaceutical University.

        http://dx.doi.org/10.1016/j.ajps.2015.11.027

        1818-0876/?2016 Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).

        一区=区三区国产视频| 少妇饥渴xxhd麻豆xxhd骆驼| 久热这里只有精品99国产| 亚洲一区二区三区免费av在线| 网站在线观看视频一区二区| 在线播放真实国产乱子伦| 亚洲欧美日韩综合久久| 国产性一交一乱一伦一色一情| 青青草久久久亚洲一区| 亚洲精品无码不卡在线播he| 国产免费丝袜调教视频| 亚洲欧美日韩高清中文在线 | 精品国产一区二区三区久久久狼| 国产亚洲无码1024| 不卡一区二区三区国产| 欧美大屁股xxxx高跟欧美黑人| 久久天天躁狠狠躁夜夜爽| 精品久久久无码不卡| 中文字幕久久久人妻人区| 最新国产精品久久精品| 成人免费xxxxx在线视频| 99精品又硬又爽又粗少妇毛片| 亚洲偷自拍国综合第一页| 一本色综合久久| 中文字幕亚洲人妻系列| 中文字幕在线亚洲精品一区| 好紧好爽免费午夜视频| 久久国产36精品色熟妇| 精品国产又大又黄又粗av| 国产精品午夜夜伦鲁鲁| 国产精品无码专区av在线播放| 国产WW久久久久久久久久| 国产不卡av一区二区三区 | 91久久久久无码精品露脸| 久久久人妻丰满熟妇av蜜臀| 久久精品99国产精品日本| 国产人妻精品一区二区三区不卡| 国产成人啪精品视频免费网| 日本一区二区在线免费看| 日韩视频中文字幕精品偷拍| 国产麻豆一精品一AV一免费软件|